Motor Neuron Disease Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Motor Neuron Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2Phase 3

Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

Motor Neuron Disease / Amyotrophic Lateral Sclerosis
University of Edinburgh1,150 enrolled22 locationsNCT04302870
Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Movement DisordersAmyotrophic Lateral SclerosisDegenerative Disorder+1 more
Target ALS Foundation, Inc.1,000 enrolled12 locationsNCT05137665
Recruiting

Digital App for Speech & Health Monitoring

DementiaMultiple SclerosisParkinson Disease+1 more
University of Edinburgh150 enrolled1 locationNCT06450418
Recruiting

Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases

Multiple System AtrophyParkinson DiseaseMotor Neuron Disease+2 more
Kliniken Beelitz GmbH350 enrolled16 locationsNCT04706234
Recruiting
Not Applicable

Non-invasive BCI-controlled Assistive Devices

Traumatic Brain InjuryHealthyMovement Disorders+6 more
University of Texas at Austin100 enrolled1 locationNCT05183152
Recruiting

ALS Research Collaborative

Amyotrophic Lateral SclerosisMotor Neuron DiseaseALS (Amyotrophic Lateral Sclerosis)+2 more
ALS Therapy Development Institute2,000 enrolled1 locationNCT06885918
Recruiting

Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease

Multiple SclerosisPrimary Lateral SclerosisMotor Neuron Disease / Amyotrophic Lateral Sclerosis+2 more
University of Dublin, Trinity College240 enrolled1 locationNCT06320444
Recruiting
Not Applicable

Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease

Motor Neuron Disease / Amyotrophic Lateral Sclerosis
University of Melbourne244 enrolled13 locationsNCT05136222